The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...

Our community has shared frustration over NHS barriers to prostate cancer screening, welcoming David Cameron’s call for ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

The PSA test is an imperfect way to screen men for prostate cancer. But until recently, it was seen as the best option available. The test measures the amount of prostate specific antigen, or PSA, in ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

The NHS does not offer routine prostate cancer screening for all men. The PSA (prostate-specific antigen) test, which ...

For men between the ages of 55 and 69, getting screened for prostate cancer is a mixed bag of possible, down-the-road benefits and just-as-possible immediate harms. That means there’s no one-size-fits ...